ArticleRedox report : communications in free radical research2013

The redox-active, anti-cancer drug Dp44mT inhibits T-cell activation and CD25 through a copper-dependent mechanism.

Danuta S Kalinowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.